Radiology Business February 23, 2024
Over 134,000 U.S. cancer cases went undiagnosed during the peak of the COVID-19 pandemic, according to new data published Thursday in JAMA Oncology [1].
Cancers of the prostate (17%), female breast (13%), and lung (12%) accounted for the largest share of the tally, experts noted. Overall, screenable cancers saw a total rate reduction of nearly 14% during the time span between March and December 2020, compared to expected diagnosis rates.
University of Kentucky researchers believe these data offer key clues as radiology providers confront advanced cancer cases in the coming years.
“The U.S. experienced significant differences between observed and expected cancer incidence rates during the COVID-19 pandemic in 2020, with an associated and substantial deficit in diagnosed cases,” Todd...
Today's Sponsors
Today's Sponsor